Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Empagliflozin 25 mg vs JARDIANCE in Healthy Thai Volunteers Under Fasting
TCTR20251107001Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of empagliflozin (2 arms), sponsored by Bio-innova. Planned start May 2026; status: not yet recruiting.
02
Drugs
empagliflozin
Beyond the preview
Go deeper on TCTR20251107001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251107001.